Purchase Order 75N91019P00778
Award Date
9/12/19
Potential Completion Date
9/11/22
Potential Value
$135K
Federal Agency
National Cancer Institute
Awardee
Tempus AI, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60654, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Tempus AI, Inc. (doing business as Tempus Labs Inc.) is for tumor normal matched genomic testing services for the U.S. Department of Veterans Affairs (VA). The $5,718,045.00 firm fixed price delivery order contract, awarded on January 28, 2025, has a performance period extending through January 27, 2027. Tempus Labs Inc. is an experienced provider of genomic sequencing and precision medicine services to the VA, holding a larger $64,296,441.00 Indefinite Delivery...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Tempus AI, Inc. (doing business as Tempus Labs Inc.) for tumor normal matched genomic testing services. The contract has a ceiling value of $325,119.50 and a performance period through September 25, 2023. Tempus Labs is a technology company specializing in precision medicine and genomic sequencing services. This contract supports the VA's precision oncology initiatives for veteran cancer...
This contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Akesogen, Inc.'s Tempus Labs division for DNA extraction services. The $5,286.10 firm-fixed-price purchase order does not have a set-aside designation. Tempus Labs is a for-profit technology company that specializes in advanced genomic analysis services, primarily supporting large-scale biomedical research programs conducted by federal agencies like the Department of...
This firm fixed price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Tempus AI, Inc. (Tempus Labs Inc.) to provide DNA methylation and genome-wide association services to evaluate changes in epigenetic aging for veterans with HIV who participated in a telehealth-delivered high-intensity exercise study. The contract has a ceiling value of $67,572.00 and a period of performance through September 29, 2025. There is no set-aside designation for this requirement....
The Department of Veterans Affairs (VA) awarded a $2,022,406 Firm Fixed Price Delivery Order contract to Tempus Labs Inc., doing business as Tempus, to provide Tumor Normal Matched Genomic Testing Services. Tempus will perform genomic testing services on tumor and normal tissue samples from VA patients to identify genomic variants that may be targeted for precision cancer therapies. The contract has a one-year period of performance starting January 28, 2022 through January 27, 2023 and will be...
This is a $4,000,000.00 firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters to Akesogen, Inc.'s Tempus Labs, Inc. division for genomic analysis services. The contract has a period of performance through July 21, 2025 and is not designated as a set-aside. Tempus Labs, a for-profit technology company, will provide genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular...
This is a firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters (VA HQ) to Akesogen, Inc.'s Tempus Labs division. The contract, valued at $10,477,738.83, tasks Tempus Labs with providing genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services in support of the VA's biomedical research programs. The work is performed at the VA HQ in Washington, D.C. with...
The Department of Veterans Affairs (VA) Headquarters awarded a firm fixed price delivery order contract to Akesogen, Inc.'s Tempus Labs, Inc. division, a for-profit technology company that provides genomic sequencing and analysis services. The $13,020,379.40 contract tasks Tempus Labs with conducting genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services to support the VA's biomedical research programs,...
This is a $884,040.57 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the acquisition of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract was awarded to Indivumed, Inc., a for-profit organization, and is not set aside for any special designation. The contract is a delivery order under the NCI Cancer...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...